[GTOP] [HELP] [ORGANISMS] [SEARCH] [SUMMARY]
Nocardia farcinica IFM 10152 (nfar0)
Gene : purL
DDBJ      :purL         putative phosphoribosylformylglycinamidine synthase II
Swiss-Prot:PURL_NOCFA   RecName: Full=Phosphoribosylformylglycinamidine synthase 2;         EC=6.3.5.3;AltName: Full=Phosphoribosylformylglycinamidine synthase II;         Short=FGAM synthase II;

Homologs  Archaea  60/68 : Bacteria  808/915 : Eukaryota  148/199 : Viruses  0/175   --->[See Alignment]
a.5.10d.139.1d.79.4
:764 amino acids
:SECSTR
:PSIPRED
:DISOPRED
:BLT:PDB   34->581 2hs3A PDBj 2e-95 43.5 %
:RPS:PDB   29->707 3d54A PDBj 1e-97 37.0 %
:RPS:SCOP  29->207 1vk3A1  d.79.4.1 * 2e-27 47.5 %
:RPS:SCOP  216->398 1t3tA6  d.139.1.1 * 2e-47 30.6 %
:RPS:SCOP  425->584 1vk3A2  d.79.4.1 * 3e-47 32.9 %
:RPS:SCOP  592->754 1t3tA7  d.139.1.1 * 5e-17 20.5 %
:HMM:SCOP  21->61 1t3tA1 a.5.10.1 * 1.3e-10 46.3 %
:HMM:SCOP  43->208 1vk3A2 d.79.4.1 * 1.8e-48 40.0 %
:HMM:SCOP  210->447 1t3tA7 d.139.1.1 * 6.1e-58 39.5 %
:HMM:SCOP  408->588 1t3tA5 d.79.4.1 * 1.4e-52 43.6 %
:HMM:SCOP  593->758 1t3tA6 d.139.1.1 * 7.4e-42 41.6 %
:RPS:PFM   104->182 PF00586 * AIRS 8e-13 47.4 %
:RPS:PFM   258->372 PF02769 * AIRS_C 2e-13 40.9 %
:RPS:PFM   462->555 PF00586 * AIRS 1e-04 30.9 %
:RPS:PFM   648->730 PF02769 * AIRS_C 2e-05 36.0 %
:HMM:PFM   215->374 PF02769 * AIRS_C 5.6e-32 36.5 148/151  
:HMM:PFM   594->731 PF02769 * AIRS_C 2.6e-26 33.8 136/151  
:HMM:PFM   87->182 PF00586 * AIRS 4.1e-28 41.9 93/96  
:HMM:PFM   462->557 PF00586 * AIRS 1.2e-19 35.2 91/96  
:BLT:SWISS 1->764 PURL_NOCFA 0.0 100.0 %
:REPEAT 2|15->391|392->753
:SEG

SeqInfo AminoSeq See neighboring genes
Links GIB DAD Abbreviations Back to title page
GT:ID BAD55418.1 GT:GENE purL GT:PRODUCT putative phosphoribosylformylglycinamidine synthase II GT:DATABASE GIB00210CH01 GT:ORG nfar0 GB:ACCESSION GIB00210CH01 GB:LOCATION 589940..592234 GB:FROM 589940 GB:TO 592234 GB:DIRECTION + GB:GENE purL GB:PRODUCT putative phosphoribosylformylglycinamidine synthase II GB:PROTEIN_ID BAD55418.1 LENGTH 764 SQ:AASEQ MTPQVDTVSAAAATPDVAQPYKELGLKDDEYARIKEILGRRPTDAELAMYSVMWSEHCSYKSSKVHLRYFGETTTEEMRKSMLAGIGENAGVVDVGDGWAVTFKVESHNHPSYVEPYQGAATGVGGIVRDIMAMGARPVAVMDQLRFGAADHPDTRRVVDGVVRGIGGYGNSLGLPNVGGETVFDASYQGNPLVNALCAGVMRVEDLHLAFASGTGNKIILFGARTGLDGIGGVSVLASDTFSGDESGAGRKKLPSVQVGDPFTEKVLIECCLELYAAKLVVGIQDLGGAGLSCATSELAAAGDGGMRIELDKVPLRAADMTPAEILSSESQERMCAVVTPENVEAFMAVCRKWDVLATVIGEVTDGDRLVVTWHGETVVDVPPRTVAHEGPVYERPVQRPDYQDALIADTPDTLPRPATADELRETLLRMISSPQLCSRKWITEQYDRYVRGNTVLAEDADAGVIRIDEQTGRGIALATDASGRYTKLDPYAGAQLALAEAFRNVASTGATPKAVTNCLNFGSPEDPGVMWQFQQAVRGLADGCVALGIPVTGGNVSFYNQTGQDAILPTPVVGVLGVIDDVHRRIPTGIGLEPGETLILLGDTRDEFGGSIWAQVVHDHLGGVPPKVDFAREQLLAEVLTAGSRDGMISAAHDLSEGGLAQAVVEAALAGETGCRILLPEDADPFVTLFSESAGRVLVAVPRSEETRFTRMCEARQLPWVRIGVVDQGSDALEVQGHFSIPLTELRAAFEGTLPKLFGAETA GT:EXON 1|1-764:0| SW:ID PURL_NOCFA SW:DE RecName: Full=Phosphoribosylformylglycinamidine synthase 2; EC=6.3.5.3;AltName: Full=Phosphoribosylformylglycinamidine synthase II; Short=FGAM synthase II; SW:GN Name=purL; OrderedLocusNames=NFA_5730; SW:KW ATP-binding; Complete proteome; Cytoplasm; Ligase; Nucleotide-binding;Purine biosynthesis. SW:EXACT T SW:FUNC + BL:SWS:NREP 1 BL:SWS:REP 1->764|PURL_NOCFA|0.0|100.0|764/764| GO:SWS:NREP 5 GO:SWS GO:0005524|"GO:ATP binding"|ATP-binding| GO:SWS GO:0005737|"GO:cytoplasm"|Cytoplasm| GO:SWS GO:0016874|"GO:ligase activity"|Ligase| GO:SWS GO:0000166|"GO:nucleotide binding"|Nucleotide-binding| GO:SWS GO:0006164|"GO:purine nucleotide biosynthetic process"|Purine biosynthesis| NREPEAT 1 REPEAT 2|15->391|392->753| SEG 91->98|gvvdvgdg| SEG 156->168|rrvvdgvvrgigg| BL:PDB:NREP 1 BL:PDB:REP 34->581|2hs3A|2e-95|43.5|494/602| RP:PDB:NREP 1 RP:PDB:REP 29->707|3d54A|1e-97|37.0|575/583| RP:PFM:NREP 4 RP:PFM:REP 104->182|PF00586|8e-13|47.4|76/97|AIRS| RP:PFM:REP 258->372|PF02769|2e-13|40.9|115/148|AIRS_C| RP:PFM:REP 462->555|PF00586|1e-04|30.9|89/97|AIRS| RP:PFM:REP 648->730|PF02769|2e-05|36.0|83/148|AIRS_C| HM:PFM:NREP 4 HM:PFM:REP 215->374|PF02769|5.6e-32|36.5|148/151|AIRS_C| HM:PFM:REP 594->731|PF02769|2.6e-26|33.8|136/151|AIRS_C| HM:PFM:REP 87->182|PF00586|4.1e-28|41.9|93/96|AIRS| HM:PFM:REP 462->557|PF00586|1.2e-19|35.2|91/96|AIRS| GO:PFM:NREP 2 GO:PFM GO:0003824|"GO:catalytic activity"|PF00586|IPR000728| GO:PFM GO:0003824|"GO:catalytic activity"|PF00586|IPR000728| RP:SCP:NREP 4 RP:SCP:REP 29->207|1vk3A1|2e-27|47.5|160/165|d.79.4.1| RP:SCP:REP 216->398|1t3tA6|2e-47|30.6|160/168|d.139.1.1| RP:SCP:REP 425->584|1vk3A2|3e-47|32.9|155/162|d.79.4.1| RP:SCP:REP 592->754|1t3tA7|5e-17|20.5|162/217|d.139.1.1| HM:SCP:REP 21->61|1t3tA1|1.3e-10|46.3|41/0|a.5.10.1|1/1|FGAM synthase PurL, linker domain| HM:SCP:REP 43->208|1vk3A2|1.8e-48|40.0|160/0|d.79.4.1|1/2|PurM N-terminal domain-like| HM:SCP:REP 210->447|1t3tA7|6.1e-58|39.5|215/217|d.139.1.1|1/2|PurM C-terminal domain-like| HM:SCP:REP 408->588|1t3tA5|1.4e-52|43.6|181/200|d.79.4.1|2/2|PurM N-terminal domain-like| HM:SCP:REP 593->758|1t3tA6|7.4e-42|41.6|166/0|d.139.1.1|2/2|PurM C-terminal domain-like| OP:NHOMO 1047 OP:NHOMOORG 1016 OP:PATTERN --11--1111111111-111111111111111111111111111111111111111111-1111--11 1111111111111111111-1111111111111111111111111111111111111111111111111111111111111111111111111111---11111121111---------------11111111111111111111111111111111111111111111111111111111111111111-1111111111111111111111111111111111111111111111111111111111111111-11111-1-1111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111-11111111111111111111111111111111111111111111111111111111111111111---------------111111111111111111111111111111111111111111111111111-111111111112111111111111111111111111111111111111111111111111111111111111-1-------11111111111111111111111111111111111111-11111------11111111111111111-1111111111111-111111111111111111111111111111111111111111111111111--1111111111111111111111-111111111111111111111111111111111111111111111111111111111111111--------1---1111111111--------1---------------------------1-11111111121 ----111-----11111111111----111111111111---111111111111--1-1111111111-11111111-1111111111-12111-111111-1111-1--21-111--1-111121111161112211--1--1--1-111---1--111--13---3111111-1111811--121221111121111 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- STR:NPRED 717 STR:RPRED 93.8 SQ:SECSTR #######################ccccHcTHHHHHHHHcccccHHHHHHHHHHTccccccTTTHHHHHHccGGcEEEccTTEEccccccTTEEEccccEEEEEEEEEccHHHHHccHHHHHHHHHHHHHHHHTTTcEEEEEEEEEEEccccHHHHccccHHHHHHHHHHHGGGTccEEEEEEEEcTTcTTccEEEEEEEEEEEGGGcccccccccccEEEEEEccccccccccHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHHTTcccEEEEccccTHHHHHTHHHHTTTcEEEEEGGGcccccTTccHHHHHccccccEEEEEEcTTccTTHHHHHHHTTcEEEEEEEEEcccEEEEEETTEEEEEEETHHHHccccccccccccccccccccccccccHHHHHHHHHHTEEEccccccccccccHHHHTTccccTTccccccTTcccEEcccTTEEccEEEEEEEccHHHHHHcTTHHHHHHHHHHHHHHHTTTcEEEEEEccEEcccTTTccHHHHHHHHHHHHHHHHHHccccEEEcccccccEETTEEcccEEcEEEEEEEcTETccccTcccccccEEEEEEEEccccGGGcHHHHHHHccccHHHHHHHHHHHcccccGGGHHHHHHHTTTcEEEccTTcccHHHHHHHHTTcEEEEcccccccccEEEEEcccccccccEEEEEEcTTHHHHHHHTcccEEEEEEEccccEccccccc######################## DISOP:02AL 763-764| PSIPRED cccccccHHHHHHHHHHHHHHHHccccHHHHHHHHHHHcccccHHHHHHHHHHccccccEEccHHHHHHcccccHHHccccEEEEccccEEEEEccccEEEEEEEcccccccEEcccccccEEEEEEEEEEEcccccHHHEEEEEEccccccHHHHHHHHHHHHHHHHHHHHcccEEEEEEEEEccccccccEEEEEEEEEEEcccEEcccccccccEEEEEccccccccccHHHHHHHHHHHHHHHHHHHHcccHHHcccHHHHHHHHHHHHHHHHcccEEEccccccccHHHHHHHHHHHcccEEEEEEHHcccccccccHHHHHHccccccEEEEEcHHHHHHHHHHHHHccccEEEEEEEEEccEEEEEEcccEEEEcccHHHcccccEEEccccccccHHHHccccHHHcccccccccHHHHHHHHHcccccccccccEEEEEEEEcccEEEEccccEEEEEEcccccEEEEEEEcccccccEEcHHHHHHHHHHHHHHcEEEccccHHHEEEEEEccccccccHHHHHHHHHHHHHHHHHHccccEEEccEEEEcccccccccccEEEEEEEEEcccccccccccccccccEEEEEccccccHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHcccEEEEEccccccHHHHHHHHHHHcccEEEEEEcccccHHHHHHcccccEEEEEEcHHHHHHHHHHHHHccccEEEEEEEEccccEEEEccEEEEcHHHHHHHHHHHHHHHcccccc //